Updates on Urothelial Carcinoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 January 2026 | Viewed by 62
Special Issue Editors
Interests: prostate cancer; urothelial cancer; kidney cancer: biomarker; cancer diagnosis; tumor microenvironment
Special Issue Information
Dear Colleagues,
Urothelial carcinoma remains a significant challenge in oncology, with ongoing research efforts aiming to improve patient outcomes. This Special Issue will provide a comprehensive update on the latest advancements in urothelial carcinoma management, focusing both on upper tract and bladder cancers.
This Special Issue will provide a thorough update on urothelial carcinoma management, focusing on therapeutic innovations and large-scale surgical outcome analyses. The scope spans emerging systemic therapies and critical evaluations of cystectomy outcomes across diverse patient populations. Contributions should explore evolving therapeutic strategies, including the novel targeted therapies, immunotherapies, and combination approaches that are reshaping the treatment landscape.
Key focus areas include the following:
- The molecular and genomic targets driving personalized medicine approaches;
- The role of urine- and blood-based biomarkers in detection and follow-up in bladder cancer;
- Innovations in perioperative therapy, including neoadjuvant and adjuvant treatments;
- Advancements in metastatic disease management, with an emphasis on new first-line options;
- The role of circulating tumour DNA (ctDNA) as a biomarker across the disease spectrum;
- Bladder preservation strategies for select patients;
- Long-term outcomes in cystectomy patients;
- Ongoing clinical trials and their potential impacts on future treatment paradigms.
This Special Issue will provide clinicians and researchers with a detailed picture of the current state of urothelial carcinoma care, highlighting both the progress made and the challenges that lie ahead in improving patient outcomes.
Prof. Dr. Toyonori Tsuzuki
Dr. Yasmin Abu-Ghanem
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- urothelial carcinoma
- systemic therapy
- molecular biomarkers
- personalized medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
